Increased Factor VIII Associated Activities in Cushing's Syndrome: A Probable Hypercoagulable State

Summary

Thirteen women and 2 men affected by Cushing’s syndrome were investigated. The following parameters were used: plasma and urinary cortisol levels, factor VIII assay (antigen, activity and von Willebrand factor) together with other coagulative assays.

Samples were taken before surgery or before medical and/or radiation therapy and every 30–50 days after treatment and continued for 11 months. Cortisol and factor VIII were increased before treatment and decreased slowly after treatment to become normal in 3–4 months. Other clotting tests did not show significant changes. It seems that high plasma cortisol levels may stimulate the production of factor VIII. Patients with Cushing’s syndrome often exhibit thromboembolic complications after surgery. It is likely that the clotting abnormalities responsible for such complications is the increased factor VIII activities level.

Key words

Factor VIII - Cushing’s syndrome - Hypercoagulable state

• References

• 1 Blichert-Toft M, Bagerskov A, Lockwood K, Hasner E. Operative treatment, surgical approach, and related complications in 195 operations upon the adrenal glands. Surg Gynecol Obstet 1972; 135: 261-266
• 2 Ernest I, Ekman H. Adrenalectomy in Cushing’s disease: a long-term follow-up. Acta Endocrinol 1972; (Suppl. 160) 5-41
• 3 Pezzulich RA, Mannix H. Immediate complications of adrenal surgery. Ann Surg 1970; 172: 125-130
• 4 Sjöberg HE, Blomback M, Granberg PO. Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing’s syndrome. Acta Med Scand 1976; 199: 95-98
• 5 Cliffton EE, Cannamella DA. Fibrinolytic and proteolytic activity of human plasminogen prepared from fraction III of human plasma. J Appl Physiol 1953; 6: 42-46
• 6 Fabris F, Franzoso R, De Marco L, Virgolini L, Burul A, Dal Bo Zanon R, Fioretti D, Girolami A. L’angioemofilia o malattia di von Willebrand. Prog Med 1977; 33: 710-722
• 7 Girolami A, Sticchi A, Barbui T, Bareggi G. Factor VIII immunological assay. An evaluation of several methods using whole plasma. Blut 1974; 29: 309-316
• 8 Girolami A, Cella G, Patrassi G. Increased whole blood viscosity on cooling in a patient with cold hemoagghitinin disease. Vox Sang 1976; 31 (Suppl. 01) 1-8
• 9 Boscaro M, Karbowiak I, Mantero F. Radioimmunoassay of free urinary cortisol: clinical applications. J Nucl Med Allied Sci 1977; 21: 61-62
• 10 Ozsoylu S, Strauss HS, Diamond LK. Effect of corticosteroids on coagulation of the blood. Nature 1962; 195: 1214-1215
• 11 Chatterjea JB, Salomon L. Antagonistic effect of A. C. T. H. and cortisone on the anticoagulant activity of ethyl biscoumacetate. Br Med J 1954; 2: 790-792
• 12 Cosgriff SW, Diefenbach AF, Vogt W. Hipercoagulability of the blood associated with A. C. T. H. and cortisone therapy. Am J Med 1950; 9: 752-756
• 13 Isacson S. Effect of prednisolone on the coagulation and fibrinolytic systems. Scand J Haematol 1970; 7: 212-216
• 14 Russek HI, Zohmann BL, Russek AS. Risk of thromboembolic complications from cortisone therapy. Am Heart J 1954; 47: 653-657